Literature DB >> 27221332

In Vivo Effects of Mesenchymal Stromal Cells in Two Patients With Severe Acute Respiratory Distress Syndrome.

Oscar E Simonson, Dimitrios Mougiakakos, Nina Heldring, Giulio Bassi, Henrik J Johansson, Magnus Dalén, Regina Jitschin, Sergey Rodin, Matthias Corbascio, Samir El Andaloussi, Oscar P B Wiklander, Joel Z Nordin, Johan Skog, Charlotte Romain, Tina Koestler, Laila Hellgren-Johansson, Petter Schiller, Per-Olof Joachimsson, Hans Hägglund, Mattias Mattsson, Janne Lehtiö, Omid R Faridani, Rickard Sandberg, Olle Korsgren, Mauro Krampera, Daniel J Weiss, Karl-Henrik Grinnemo, Katarina Le Blanc.   

Abstract

Entities:  

Year:  2016        PMID: 27221332      PMCID: PMC4878323          DOI: 10.5966/sctm.2015-0021erratum

Source DB:  PubMed          Journal:  Stem Cells Transl Med        ISSN: 2157-6564            Impact factor:   6.940


× No keyword cloud information.
S 2015;4:1199–1213; first published on August 18, 2015; http://dx.doi:10.5966/sctm.2015-0021 In the Materials and Methods section, the Ethical Considerations paragraph incorrectly noted the regulatory permit approval numbers for this study. The first sentence of the paragraph should have stated the following: The production of clinical-grade MSCs was accredited by the Swedish National Board of Health and Welfare (approval numbers 6.3.3-8874-2011 and 6.1.3-9791/2013). The authors regret the error, which has been corrected in the online version of the article.
  12 in total

1.  Cell therapy for acute respiratory distress syndrome patients: the START study.

Authors:  Fernanda Ferreira Cruz; Patricia Rieken Macedo Rocco
Journal:  J Thorac Dis       Date:  2019-05       Impact factor: 2.895

Review 2.  Biological functions of mesenchymal stem cells and clinical implications.

Authors:  Abderrahim Naji; Masamitsu Eitoku; Benoit Favier; Frédéric Deschaseaux; Nathalie Rouas-Freiss; Narufumi Suganuma
Journal:  Cell Mol Life Sci       Date:  2019-05-04       Impact factor: 9.261

Review 3.  Cell therapy in acute respiratory distress syndrome.

Authors:  Shahd Horie; Hector Esteban Gonzalez; John G Laffey; Claire H Masterson
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

Review 4.  Mesenchymal stem cells in idiopathic pulmonary fibrosis.

Authors:  Xiaohong Li; Shaojie Yue; Ziqiang Luo
Journal:  Oncotarget       Date:  2017-05-23

Review 5.  Mesenchymal stem/stromal cell function in modulating cell death.

Authors:  Abderrahim Naji; Benoit Favier; Frédéric Deschaseaux; Nathalie Rouas-Freiss; Masamitsu Eitoku; Narufumi Suganuma
Journal:  Stem Cell Res Ther       Date:  2019-02-13       Impact factor: 6.832

Review 6.  Stem cells and COVID-19: are the human amniotic cells a new hope for therapies against the SARS-CoV-2 virus?

Authors:  Rodrigo N Riedel; Antonio Pérez-Pérez; Víctor Sánchez-Margalet; Cecilia L Varone; Julieta L Maymó
Journal:  Stem Cell Res Ther       Date:  2021-03-01       Impact factor: 6.832

7.  Combined Mesenchymal Stromal Cell Therapy and Extracorporeal Membrane Oxygenation in Acute Respiratory Distress Syndrome. A Randomized Controlled Trial in Sheep.

Authors:  Jonathan E Millar; Nicole Bartnikowski; Margaret R Passmore; Nchafatso G Obonyo; Maximillian V Malfertheiner; Viktor von Bahr; Meredith A Redd; Louise See Hoe; Katrina K Ki; Sanne Pedersen; Andrew J Boyle; J Kenneth Baillie; Kiran Shekar; Nathan Palpant; Jacky Y Suen; Michael A Matthay; Daniel F McAuley; John F Fraser
Journal:  Am J Respir Crit Care Med       Date:  2020-08-01       Impact factor: 21.405

Review 8.  Mesenchymal stem/stromal cells: the therapeutic effects in animal models of acute pulmonary diseases.

Authors:  Sirous Sadeghian Chaleshtori; Mohammad Reza Mokhber Dezfouli; Massoumeh Jabbari Fakhr
Journal:  Respir Res       Date:  2020-05-11

9.  Short-term physiological hypoxia potentiates the therapeutic function of mesenchymal stem cells.

Authors:  Ben Antebi; Luis A Rodriguez; Kerfoot P Walker; Amber M Asher; Robin M Kamucheka; Lucero Alvarado; Arezoo Mohammadipoor; Leopoldo C Cancio
Journal:  Stem Cell Res Ther       Date:  2018-10-11       Impact factor: 6.832

Review 10.  COVID-19 vaccines: The status and perspectives in delivery points of view.

Authors:  Jee Young Chung; Melissa N Thone; Young Jik Kwon
Journal:  Adv Drug Deliv Rev       Date:  2020-12-24       Impact factor: 17.873

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.